Study of AZD5863 in Adult Participants With Advanced or Metastatic Solid Tumors
Recruiting now · Phase 1/Phase 2
Conditions studied: Gastric Cancer, Gastro-esophageal Junction Cancer, Pancreatic Ductal Adenocarcinoma, Esophageal Adenocarcinoma
In brief
This research is designed to determine if experimental treatment with AZD5863, a T cell-engaging bispecific antibody that targets Claudin 18.2 (CLDN18.2) and CD3, is safe, tolerable and has anti-cancer activity in patients with advanced solid tumors.
Key facts
- Study ID
- NCT06005493
- Run by
- AstraZeneca
- People needed
- 280
- Starts
- 2023-07-11
- Expected to finish
- 2027-07-16
- Last updated by the study team
- 2026-02-24
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Research Site — Oxford, United Kingdom (enrolling)
- Research Site — Rochester, Minnesota, United States (enrolling)
- Research Site — Jacksonville, Florida, United States (enrolling)
- Research Site — Beijing, China (enrolling)
- Research Site — Beijing, China (enrolling)
- Research Site — Shandong, China (enrolling)
- Research Site — Toulouse, France (enrolling)
- Research Site — Villejuif, France (enrolling)
- Research Site — Chūōku, Japan (enrolling)
- Research Site — Kashiwa, Japan (enrolling)
- Research Site — Kōtoku, Japan (enrolling)
- Research Site — Amsterdam, Netherlands (enrolling)
- Research Site — Groningen, Netherlands (enrolling)
- Research Site — Rotterdam, Netherlands (enrolling)
- Research Site — Seoul, South Korea (enrolling)
- Research Site — Seoul, South Korea (enrolling)
- Research Site — Seoul, South Korea (enrolling)
- Research Site — Seoul, South Korea (enrolling)
- Research Site — Kaohsiung City, Taiwan (enrolling)
- Research Site — Tainan, Taiwan (enrolling)
- Research Site — Taoyuan, Taiwan (enrolling)
- Research Site — Dundee, United Kingdom (enrolling)
- Research Site — London, United Kingdom (enrolling)
- Research Site — Metropolitan Borough of Wirral, United Kingdom (enrolling)
- Research Site — New York, New York, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.